StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > OMG

<< Previous

Bullboard Posts

Next >>

Comment by ElMagoon Feb 23, 2021 6:49pm

74 Views

Post# 32643032

RE:RE:RE:OMG

No new investors will want to look here given this mess of a board and managements lack of communication. Back to head in the sand.

Maybe a couple of small time investores will think twice about gambling on a few hundred shares in their mess of a portfolio, but someone who is going to buy and hold isn't basing their descision based on the content of some trashy forum. Except me

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading